Soleno Therapeutics Inc (SLNO)

Jan 15, 2025

Soleno Therapeutics Breaks Above 200-Day Moving AverageBullish for SLNO - Nasdaq

Jan 15, 2025

Jan 15, 2025

Soleno Therapeutics (NASDAQ:SLNO) Trading 8.6% HigherHere's What Happened - MarketBeat

Jan 15, 2025

Jan 15, 2025

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $74.83 Consensus PT from Brokerages - MarketBeat

Jan 15, 2025

Jan 15, 2025

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Average Recommendation of “Buy” by Brokerages - Defense World

Jan 15, 2025

Jan 14, 2025

Is Soleno Therapeutics (SLNO) the Top Small Cap Stock to Buy with the Highest Upside Potential? - MSN

Jan 14, 2025

Jan 12, 2025

Top 10 Small Cap Stocks to Buy with the Highest Upside Potential - Insider Monkey

Jan 12, 2025

Jan 11, 2025

Analysts Predict How High Soleno Therapeutics Inc (SLNO) Will Go. - Stocks Register

Jan 11, 2025

Jan 09, 2025

Have Insiders Sold Soleno Therapeutics Shares Recently? - Simply Wall St

Jan 09, 2025

Jan 07, 2025

Trading (SLNO) With Integrated Risk Controls - Stock Traders Daily

Jan 07, 2025

Jan 07, 2025

Soleno Therapeutics, Inc. (NASDAQ:SLNO): When Will It Breakeven? - Yahoo Finance

Jan 07, 2025

Jan 07, 2025

Soleno Therapeutics senior VP Patricia Hirano sells $138,709 in stock By Investing.com - Investing.com Australia

Jan 07, 2025

Jan 07, 2025

Soleno therapeutics' SVP Kristen Yen sells $222,483 in stock By Investing.com - Investing.com Australia

Jan 07, 2025

Jan 07, 2025

Soleno Therapeutics CFO James Mackaness sells $360,460 in stock By Investing.com - Investing.com South Africa

Jan 07, 2025

Jan 06, 2025

Soleno Therapeutics CFO James Mackaness sells $360,460 in stock - Investing.com India

Jan 06, 2025

Jan 06, 2025

Soleno Therapeutics CEO sells $965,515 in stock - Investing.com India

Jan 06, 2025

Jan 06, 2025

Soleno therapeutics’ SVP Kristen Yen sells $222,483 in stock By Investing.com - Investing.com Nigeria

Jan 06, 2025

Jan 06, 2025

Soleno Therapeutics CEO sells $965,515 in stock By Investing.com - Investing.com South Africa

Jan 06, 2025

Jan 06, 2025

Insider Selling: Soleno Therapeutics, Inc. (NASDAQ:SLNO) CEO Sells 10,937 Shares of Stock - MarketBeat

Jan 06, 2025

Jan 06, 2025

Insider Selling: Soleno Therapeutics, Inc. (NASDAQ:SLNO) CFO Sells 4,083 Shares of Stock - MarketBeat

Jan 06, 2025

Jan 06, 2025

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Sells $108,061.20 in Stock - MarketBeat

Jan 06, 2025

Jan 06, 2025

Soleno Therapeutics senior VP Patricia Hirano sells $138,709 in stock - Investing.com India

Jan 06, 2025

Jan 06, 2025

Soleno therapeutics' SVP Kristen Yen sells $222,483 in stock - Investing.com India

Jan 06, 2025

Jan 06, 2025

Soleno Therapeutics (NASDAQ:SLNO) Trading Down 2.5%Time to Sell? - MarketBeat

Jan 06, 2025

Jan 02, 2025

Soleno Therapeutics, Inc.'s (NASDAQ:SLNO) Path To Profitability - Simply Wall St

Jan 02, 2025

Dec 31, 2024

Investors Buy Large Volume of Soleno Therapeutics Put Options (NASDAQ:SLNO) - Defense World

Dec 31, 2024

Dec 30, 2024

Soleno Therapeutics Target of Unusually High Options Trading (NASDAQ:SLNO) - MarketBeat

Dec 30, 2024

Dec 27, 2024

(SLNO) Long Term Investment Analysis - Stock Traders Daily

Dec 27, 2024

Dec 27, 2024

Geode Capital Management LLC Buys 51,189 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World

Dec 27, 2024

Dec 27, 2024

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Stock Holdings Increased by Geode Capital Management LLC - MarketBeat

Dec 27, 2024

Dec 25, 2024

Barclays PLC Increases Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World

Dec 25, 2024

Dec 25, 2024

Barclays PLC Acquires 31,467 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO) - MarketBeat

Dec 25, 2024

Dec 21, 2024

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Average Recommendation of "Buy" by Brokerages - MarketBeat

Dec 21, 2024

Dec 19, 2024

Soleno Therapeutics is Now Oversold (SLNO) - Nasdaq

Dec 19, 2024

Dec 19, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.11 Million Stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World

Dec 19, 2024

Dec 19, 2024

Teachers Retirement System of The State of Kentucky Buys Shares of 13,001 Soleno Therapeutics, Inc. (NASDAQ:SLNO) - MarketBeat

Dec 19, 2024

Dec 19, 2024

State Street Corp Has $57.67 Million Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World

Dec 19, 2024

Dec 19, 2024

State Street Corp Buys 142,033 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO) - MarketBeat

Dec 19, 2024

Dec 17, 2024

Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC - GlobeNewswire

Dec 17, 2024

Dec 17, 2024

Soleno Therapeutics Secures Massive $200M Financing Deal for Rare Disease Drug Development - StockTitan

Dec 17, 2024

Dec 17, 2024

When (SLNO) Moves Investors should Listen - Stock Traders Daily

Dec 17, 2024

Dec 14, 2024

Soleno Therapeutics: PDUFA Extension May Be An Opportunity, But Not For Me (NASDAQ:SLNO) - Seeking Alpha

Dec 14, 2024

Dec 14, 2024

Soleno Therapeutics (NASDAQ:SLNO) & Pixie Dust Technologies (NASDAQ:PXDT) Head to Head Survey - Defense World

Dec 14, 2024

Dec 13, 2024

Soleno Therapeutics' SWOT analysis: DCCR approval could reshape PWS treatment landscape By Investing.com - Investing.com South Africa

Dec 13, 2024

Dec 13, 2024

Soleno Therapeutics' SWOT analysis: DCCR approval could reshape PWS treatment landscape - Investing.com

Dec 13, 2024

Dec 13, 2024

Wellington Management Group LLP Acquires 290,135 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO) - MarketBeat

Dec 13, 2024

Dec 12, 2024

FDA delays approval decision until March on DCCR for excessive hunger in PWS - Prader-Willi Syndrome News

Dec 12, 2024